StonvexLoading…
StonvexStonvexStonvexCore line items from STTK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.00M | $5.72M | $1.66M | $652.00K |
Operating Income | $-51.51M | $-80.57M | $-91.96M | $-103.33M |
Net Income | $-48.81M | $-75.41M | $-87.30M | $-101.94M |
EPS (Diluted) | $-0.70 | $-1.49 | $-2.05 | $-2.41 |
Total Assets | $91.03M | $91.05M | $159.56M | $205.32M |
Total Liabilities | $8.64M | $11.42M | $14.86M | $29.17M |
Cash & Equivalents | $54.19M | $57.39M | $125.63M | $47.38M |
Free Cash Flow OCF − CapEx | $-39.95M | $-60.57M | $-81.64M | $-106.11M |
Shares Outstanding | 63.28M | 47.71M | 47.26M | 42.39M |